Scientific Program
*It is based on the local time of Seoul, Korea (UTC/ GMT +9:00) Updated as of August 14
November 21 (Thu)
Educational Session 1 - Targeting RAS in Cancer
| Date & Time | 11/21(Thu) 08:30 – 10:10 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
Cell type-specific Kras mutation in gastric and pancreatic carcinogenesis
Su-Hyung Lee (Vanderbilt University, USA)
- ·
-
The way of Ras inhibitors, paved with failures
Dae Ho Lee (University of Ulsan College of Medicine)
- ·
-
To be announced
Andrew J. Aguirre (Dana-Farber Cancer Institute, USA)
- ·
-
To be announced
Eileen O’Reilly (Memorial Sloan-Kettering Cancer Center, USA)
Keynote Lecture
| Date & Time | 11/21 (Thu) 10:30 – 11:10 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
To be announced
John E. Dick (UHN Princess Margaret Cancer Center, Canada)
Plenary Session 1 - Patient Derived Models
| Date & Time | 11/21 (Thu) 12:30 – 14:10 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
Cancer research models using patient-derived xenograft(PDX) and PDX-derived organoid(PDXO)
Jong-il Kim (Seoul National University)
- ·
-
Microscale tools to simulate cancer metastasis
Seok Chung (Korea University)
- ·
-
To be announced
Berend Snijder (ETH Zurich, Switzerland)
- ·
-
To be announced
Edward Kai-Hua Chow (National University of Singapore, Singapore)
Plenary Session 2 - Tumor Heterogeneity
| Date & Time | 11/21 (Thu) 14:30 – 16:10 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
Modeling cancer timelines to unravel cancer transitions and predict prevention strategies
Dongkwan Shin(National Cancer Center)
- ·
-
Multifocal organoid capturing of colon cancer reveals pervasive intratumoral heterogenous drug responses
Soon-Chan Kim(Seoul National University)
- ·
-
To be announced
Tuomas Tammela (Memorial Sloan Kettering Cancer Center, USA)
- ·
-
To be announced
Adam C. Palmer (University of North Carolina Chapel Hill, USA)
November 22 (Fri)
Educational Session 2 - Cancer Neuroscience
| Date & Time | 11/22(Fri) 08:00 – 09:30 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
Regulation of anti-tumoral immunity via brain-bone interactions
Serk-in Park (Korea University)
- ·
-
To be announced
Varun Venkatramani (Heidelberg University, Germany)
- ·
-
To be announced
Moran Amit (The University of Texas MD Anderson Cancer Center, USA)
Plenary Session 3 - EBV Related Cancers
| Date & Time | 11/22 (Fri) 09:40 – 11:20 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
EBV-positive gastric cancer: Future perspectives and therapeutic challenges
Kyung-Mee Kim (Sungkyunkwan University)
- ·
-
Epstein-Barr virus immunity and a novel cytotoxic CD4+ T cell approach for B cell malignancies
Il-Kyu Choi (DGIST)
- ·
-
To be announced
Mu-Shen Zeng (Sun Yat-Sen University Cancer Center, China)
- ·
-
To be announced
Rajiv Khanna (QIMR Berghofer, Australia)
Waun Ki Hong Memorial Lecture
| Date & Time | 11/22 (Fri) 11:40 – 12:20 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
To be announced
Yeul Hong Kim(Yuhan Cooperation)
Plenary Session 4 - AI in Cancer Research and Treatment
| Date & Time | 11/22 (Fri) 13:40 – 15:20 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
Digital Pathology and AI for gastrointestinal and hepatobiliary cancers
Sung Hak Lee (The Catholic University of Korea)
- ·
-
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Changhwan Sung (University of Ulsan College of Medicine)
- ·
-
To be announced
Aristotelis Tsirigos (New York University, USA)
- ·
-
To be announced
Maryellen I. Giger (University of Chicago, USA)
Plenary Session 5 - Advances in Immuno-oncology
| Date & Time | 11/22 (Fri) 15:40 – 17:20 | Place | Crystal Ballroom (2F) |
|---|
- ·
-
Leveraging 4-1BB as a target for T cell activation and Treg depletion through a bispecific antibody
Sang Hoon Lee (ABL bio)
- ·
-
Deciphering natural killer cells' secretomes and their influence on immune activation
Kyung-Soon Park (CHA University)
- ·
-
To be announced
Allison Betof Warner (Stanford University, USA)
- ·
-
To be announced
Aude G. Chapuis (Fred Hutchison Cancer Center, USA)